Susquehanna International Group’s Aquestive Therapeutics AQST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.54M | Buy |
466,761
+181,119
| +63% | +$600K | ﹤0.01% | 2628 |
|
|
2025
Q1 | $828K | Buy |
285,642
+91,768
| +47% | +$266K | ﹤0.01% | 3631 |
|
|
2024
Q4 | $690K | Buy |
193,874
+38,842
| +25% | +$138K | ﹤0.01% | 3551 |
|
|
2024
Q3 | $772K | Buy |
155,032
+78,213
| +102% | +$390K | ﹤0.01% | 3039 |
|
|
2024
Q2 | $200K | Sell |
76,819
-525,170
| -87% | -$1.37M | ﹤0.01% | 4743 |
|
|
2024
Q1 | $2.56M | Buy |
601,989
+563,732
| +1,474% | +$2.4M | ﹤0.01% | 1549 |
|
|
2023
Q4 | $77.3K | Buy |
38,257
+26,040
| +213% | +$52.6K | ﹤0.01% | 5434 |
|
|
2023
Q3 | $18.7K | Sell |
12,217
-80,982
| -87% | -$124K | ﹤0.01% | 5277 |
|
|
2023
Q2 | $154K | Sell |
93,199
-23,073
| -20% | -$38.1K | ﹤0.01% | 4794 |
|
|
2023
Q1 | $133K | Buy |
+116,272
| New | +$133K | ﹤0.01% | 5112 |
|
|
2022
Q4 | – | Sell |
-23,850
| Closed | -$28K | – | 5806 |
|
|
2022
Q3 | $28K | Buy |
+23,850
| New | +$28K | ﹤0.01% | 5643 |
|
|
2022
Q2 | – | Sell |
-48,511
| Closed | -$126K | – | 5766 |
|
|
2022
Q1 | $126K | Sell |
48,511
-118,928
| -71% | -$309K | ﹤0.01% | 5059 |
|
|
2021
Q4 | $651K | Buy |
167,439
+106,165
| +173% | +$413K | ﹤0.01% | 3431 |
|
|
2021
Q3 | $267K | Sell |
61,274
-39,036
| -39% | -$170K | ﹤0.01% | 4405 |
|
|
2021
Q2 | $398K | Sell |
100,310
-29,563
| -23% | -$117K | ﹤0.01% | 4165 |
|
|
2021
Q1 | $675K | Buy |
129,873
+66,699
| +106% | +$347K | ﹤0.01% | 3493 |
|
|
2020
Q4 | $338K | Sell |
63,174
-63,438
| -50% | -$339K | ﹤0.01% | 3787 |
|
|
2020
Q3 | $615K | Buy |
+126,612
| New | +$615K | ﹤0.01% | 2805 |
|
|
2020
Q2 | – | Sell |
-98,610
| Closed | -$216K | – | 4225 |
|
|
2020
Q1 | $216K | Buy |
98,610
+64,210
| +187% | +$141K | ﹤0.01% | 3724 |
|
|
2019
Q4 | $200K | Buy |
+34,400
| New | +$200K | ﹤0.01% | 3506 |
|